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Summary
Obesity is a highly prevalent, multigenic trait that pre-
dicts increased morbidity and mortality. Here we report
results from a genome scan based on 354 markers in
513 members of 92 nuclear families ascertained through
extreme obesity and normal body weight. The average
marker interval was ∼10 cM. We examined four cor-
related obesity phenotypes, including the body-mass in-
dex (BMI) (both as a quantitative trait and as a discrete
trait with a threshold of BMI 30 kg/m2) and percent-
age of fat (both as a quantitative trait and as a discrete
trait with a threshold of 40%) as assessed by bioelectri-
cal impedance. In the initial stage of the genome scan,
four markers in 20q gave positive evidence for linkage,
which was consistent across most obesity phenotypes
and analytic methods. After saturating 20q with addi-
tional markers (25 markers total) in an augmented sam-
ple of 713 members from 124 families, we found linkage
to several markers in a region, 20q13, previously im-
plicated in both human and animal studies. Three mark-
ers (D20S107, D20S211, and D20S149) in 20q13 had
empirical P values (based on Monte Carlo simulations,
which controlled for multiple testing) .01 for single-
point analysis. In addition, the parametric, affecteds-
only analysis for D20S476 yielded a LOD score of 3.06
( ), and the affected-sib-pair test yielded aP  .00009
LOD score of 3.17 ( ). Multipoint analysesP  .000067
further strengthened and localized these findings. This
region includes several plausible candidate genes for obe-
sity. Our results suggest that one or more genes affecting
obesity are located in 20q13.
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Introduction
Obesity is an increasingly common trait that now affects
nearly one-half of the U.S. adult population (Flegal et
al. 1998). Obesity has serious consequences for health,
including increased risks for non–insulin-dependent di-
abetes mellitus (NIDDM), hypertension, and cardiovas-
cular diseases (Bray 1986). Family studies have dem-
onstrated the heritable nature of obesity, and twin and
adoption studies have shown that the familial pattern is
due primarily to genetic factors (Price et al. 1987;
Sørensen et al. 1989; Stunkard et al. 1990; Price and
Gottesman 1991). The mode of inheritance is complex,
and segregation studies have supported both polygenic
inheritance and recessive-major-gene influence (Price et
al. 1990; Moll et al. 1991; Borecki et al. 1998). There
are several monogenic and polygenic animal models of
obesity, as well as a number of candidate genes and
regions drawn from human and animal studies (Chag-
non et al. 1998).
Several major genes affecting obesity have been iden-
tified in mice (Tecott et al. 1995; Pomp et al. 1996; Dong
et al. 1997; Good et al. 1997; Huszar et al. 1997; Chag-
non et al. 1998). In humans, however, with rare excep-
tions (Jackson et al. 1997; Montague et al. 1997; Clem-
ent et al. 1998; Strobel et al. 1998), no clear relations
between specific genotypes and obesity phenotypes have
been found. Thus far, two groups have reported linkages
in the context of a genome scan; one group reported
suggestive linkage of fat percentage tomarkers in 11q21-
q22 in Pima Indians (Norman et al. 1998), and the other
group found positive linkage, for leptin levels and fat
mass, with markers in 2p21 in Mexican Americans (Co-
muzzie et al. 1997).
Here we report results from an autosomal genome
scan for measures of human obesity. After obtaining re-
sults of an initial scan, we selected one region (20q) that
provided the most consistent support for linkage across
phenotypes and across analytic methods. We saturated
this region and found linkage of markers in 20q13 to
quantitative and discrete indices of obesity. This region
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includes markers linked to obesity in other samples, as
well as several plausible candidate genes for obesity.
Families and Methods
Families
We studied nuclear families ascertained from an on-
going linkage study at the University of Pennsylvania.
The sampling design and detailed sample characteristics
have been described elsewhere (Price et al. 1998). In
brief, families were ascertained through extremely obese
probands (body-mass index [BMI] 40) and included
additional obese siblings (BMI 30) and normal-weight
siblings and parents (BMI !27). The subjects in these
families had a wide range of obese and thin phenotypes
(BMI 16.8–76.2 kg/m2; percentage of fat [%fat]
10.2–65.2), with relatively early ages at onset (54.5%
of affected individuals in whom age at onset of obesity
was20 years). Some families recruited during the early
part of the study did not meet all the requirements. We
divided one three-generation family into two nuclear
families. During the first-stage genome scan, we included
the first 92 nuclear families (91 kindreds). For saturation
mapping of chromosome 20q, a region that was prom-
ising on the basis of the first-stage scan, we added 32
families collected after the genome scan was initiated
(124 total nuclear families).
Obesity Phenotypes
We studied the BMI (kg/m2) and %fat. We used BMI
as an index of obesity, because it correlates with other
obesity measures and was available on the largest num-
ber of individuals. For relatives at remote geographic
locations who provided blood, we used self-measured
or reported height and weight. These reports have been
shown to be reasonably accurate (Reed and Price
1998b). We also examined %fat as a phenotype; %fat
was measured by bioelectric impedance (BIA; Valhalla
Scientific), which is an indirect measure of body com-
position. %Fat measures obtained from BIA correlate
well with those obtained by the hydrodensitometry
method (Price et al. 1998). We analyzed four correlated
obesity phenotypes: both BMI and %fat as both quan-
titative and discrete traits.
Quantitative traits.—We used untransformed values of
BMI and %fat for both stages of the genome scan. For
saturation of chromosome 20q only, we used two ad-
ditional phenotypes to examine potential confounding
effects of sex and age on the linkage results. First, we
used standardized residuals of BMI and %fat after con-
trolling for sex and age by means of multiple linear re-
gression. Second, we conducted a females-only analysis
by coding the males’ obesity phenotypes as unknown.
Discrete traits.—We conducted analyses using dichot-
omized phenotypes. Individuals with BMI 30 or %fat
40 were considered to be affected, and individualswith
BMI !27 or %fat !27 were considered to be unaffected.
The threshold of BMI 30 was chosen because the ma-
jority of people in this category are overfat, not merely
overweight (Bray 1978). This BMI threshold was also
used in the family-ascertainment design (Price et al.
1998). The %fat thresholds were selected to give num-
bers of affected and unaffected individuals that were
similar to those obtained from the dichotomization of
BMI. In the discrete analyses, individuals with inter-
mediate values of BMI (27–30) and %fat (27–40) were
considered unknown. Although some information may
be lost through dichotomization, we have shown that
the majority of variance in our sample is among obese
individuals rather than between obese and lean individ-
uals (Price et al. 1998). Discrete phenotypes are desirable
because they permit affecteds-only parametric analyses.
Genotyping
We initially genotyped 354 microsatellite markers
spaced, on average, 10.1 cM apart; 290 markers were
genotyped by means of ABI 373 sequencers (Applied
Biosystems), and 64 markers were manually genotyped
to reduce intervals 120 cM in the original set. The av-
erage heterozygosity for the 354 markers used in the
first-stage genome scan was .75. After the first-stage ge-
nome search, we observed that 20q markers supported
linkage, across most methods and phenotypes. We then
saturated this region with 16 additional markers to fur-
ther localize the linkage results (25 markers total). The
20q markers were, on average, 3.5 cM apart (range
0.01–12 cM).
Framework Genotyping
DNA amplification was performed by means of a
PTC100 thermocycler (MJ Research). The forward
primer of each pair was labeled with one of three fluo-
rescent dyes—FAM, HEX, or TET (Applied Biosys-
tems)—to enable detection. PCR was performed in a
final reaction volume of 20 ml. Amplification occurred
during 35 cycles, each for 30 s at 94C, 30 s at the
primer-specific annealing temperature, and 30 s at 72C.
PCR products were subjected to electrophoresis on an
ABI373 sequencer using a 12-cm well-to-read denatur-
ing 6% polyacrylamide gel, with analysis by Applied
Biosystems’ GeneScan 1.2.
Saturation Genotyping and Shortening of Marker
Intervals
PCR was conducted in a 10-ml reaction volume under
conditions appropriate for the particular marker and
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with modifications of protocols described elsewhere
(Reed et al. 1995). Alleles were scored by two readers
blind to phenotype and were checked for Mendelian
incompatibilities by means of the computer program
GENEHUNTER. Any incompatibilities were identified,
and the original films were reevaluated for scoring or
data-entry errors. Markers were rerun as required. For
the 20q saturation mapping, we assumed that any ap-
parent double recombinants were typing errors, and we
either resolved these through retyping or considered the
genotypes to be unknown. In addition, all apparent sin-
gle recombinants in 20q were examined and verified or
were retyped if necessary.
Statistical Analysis
Quantitative-trait phenotypes.—We computed two
statistics as implemented by MAPMAKER/SIBS version
2.0 (Kruglyak et al. 1996): the EM algorithm–based
Haseman-Elston regression (EMHE) (Haseman and El-
ston 1972) and the nonparametric-linkage (NPL) quan-
titative-trait–loci analysis (NPL_QTL) (Kruglyak and
Lander 1995). In contrast to the traditional Haseman-
Elston regression, the EMHE utilizes information from
the full identity by descent (IBD) distribution when com-
puting the regression between IBD and the squared phe-
notypic difference. The NPL_QTL employs the Wil-
coxon rank-sum test to evaluate the relation between
the rank of absolute phenotypic difference and IBD at
a given locus. This approach is robust to assumptions
of both normality of squared phenotypic difference and
lack of correlation between the differences and their re-
siduals. We used all sibling pairs in the analysis, and
multiple sibling pairs within families were weighted by
, as suggested byWilson and Elston (1993).S(N 1) 2
The use of phenotypes of all sibling pairs guards against
false positives resulting from violations of the assumed
underlying distribution (Kruglyak and Lander 1995).
Discrete phenotypes.—Weperformed single- andmul-
tipoint NPL analyses, as implemented by GENE-
HUNTER version 1.1 (Kruglyak et al. 1996). GENE-
HUNTER does not require assumptions related to mode
of inheritance and penetrance, and it examines whether
the allele sharing among affected relatives is greater than
expected under the null hypothesis. A greater weight is
given to families with a larger number of affected rel-
atives. We applied a weighting function of in sum-1/ q
ming the NPL scores, where q equals the number of
families. Information content was computed as de-
scribed by Kruglyak et al. (1996). After the first- and
second-stage genome scans, two additional analyses
were conducted with the saturation marker set: (1) an
affecteds-only model using the FASTLINK version of the
linkage program MLINK (Lathrop and Lalouel 1984;
Lathrop et al. 1984; Cottingham et al. 1993; Schaffer
et al. 1994) and (2) the affected-sibling-pair (ASP) anal-
ysis of Terwilliger (SIBPAIR) (Knapp et al. 1994; Kuok-
kanen et al. 1996). SIBPAIR uses the ASP mean test and
incorporates both affected and unaffected siblings to
compute a LOD score while assuming an autosomal re-
cessive mode of inheritance. This program weights mul-
tiple affected sibships by applying a weight factor, 2/N,
where N is the number of affected siblings. N affected
siblings in a sibship contribute pairs (Suarez andN 1
Van Eevdenegh 1984; Blackwelder and Elston 1985). A
simulation study by Davis and Weeks (1997) has shown
SIBPAIR to be a consistently powerful method across
different models.
Allele frequencies.—For all analyses, we assumed a
susceptibility-gene frequency of .01 and used marker-
allele frequencies based on data on all individuals who
provided DNA. This approach gives asymptotically un-
biased estimates of the allele frequencies, thereby re-
ducing the risk of false positives (Ott 1992). Allele fre-
quencies were estimated separately for the framework
and saturation samples. For a subset of analyses, we
conducted separate analyses on Caucasian and African
American families, using race-specific allele frequencies
to control for possible differences between the two
groups.
Genetic Map
To estimate locus order and intermarker distance, we
used the map distances from the Whitehead Institute for
Biomedical Research/MIT Center for Genome Research
(WI) (Dib et al. 1996). For markers not found in the WI
database, we consulted The Cooperative Human Link-
age Database (Sheffield et al. 1995), The Genetic Lo-
cation Database (Collins et al. 1996), and The Genome
Database. Because locus order for some of the markers
for the chromosome 20 saturation map was equivocal
among different databases, we used the locus order sug-
gested by results from MultiMap (Matise et al. 1994)
analyses of our own data.
Simulations
Because we conducted multiple analyses of obesity
phenotypes for multiple markers, we completed a sim-
ulation study to estimate the genomewide, empirical P
values for single-point linkage analyses. Simulations
were conducted by means of the computer program
SIMULATE (Terwilliger and Ott 1994); this program
assumes that there is no linkage between a trait and
markers. Using the 92 nuclear families from our study,
we simulated markers having five alleles with equal fre-
quency (heterozygosity .80) and placed 10 cM apart.
Thus, all markers were simulated to be unlinked to the
trait, but the adjacent markers were linked at a distance
of 10 cM.
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Table 1
Characteristics of Families in the First and Second Stages of the
Genome Scan
First-Stage Scan
Additional
for Second-
Stage Scan
No. of families 92 32
No. of individuals 513 200
No. of sibling pairs with measured
BMI values 487 163
Mean BMI (SD) 35.2 (10.9) 34.1 (10.4)
No. of sibling pairs with measured
%fat values 306 117
Mean %fat (SD) 41.3 (10.8) 39.1 (12.2)
No (%) of siblings with BMI 30 144 (59.8) 38 (36.5)
No. (%) of siblings with %fat 40 87 (36.8) 21 (20.2)
% African American families 10.8 32.3
To estimate the genomewide P values, we simulated
100 replicates for 35 sets of 10 linked markers, thereby
creating 35,000 replicates, roughly simulating linkage
groups spanning the genome. We then conducted six
analyses of each of the replicates. Four different phe-
notypes were used: BMI 30 (NPL statistic), BMI as a
quantitative trait (EMHE and NPL_QTL statistics),
%fat 40 (NPL statistic), and %fat as a quantitative
trait (EMHE and NPL_QTL statistics). Thus, we com-
pleted a total of 210,000 analyses assuming the same
parameters, except for allele frequencies, as those that
were used in analyses of the real data. To estimate anal-
ysis-specific (single test) P values, we computed the em-
pirical P values by dividing the number of replicates that
exceeded the observed nominal P value for that partic-
ular test by the total number of replicates (35,000 tests
of 35,000 replicates). To control for multiple testing, we
computed empirical P values by dividing the number of
replicates that exceeded the observed P value for any of
the six tests (210,000 total) by the total number of rep-
licates (35,000).
Results
Subjects
In the first stage of the genome scan, we studied 92
nuclear families from 91 kindreds having 513 individ-
uals (table 1). The overall mean BMIwas 35.2 (SD 10.9),
and the overall mean%fat was 41.3 (SD 10.8). For BMI,
there were 487 sibling pairs, and 144 individual siblings
had BMI 30. For %fat, there were 306 sibling pairs,
and 87 individual siblings had %fat 40. In the second
stage, we included 32 additional families, for a total of
124 nuclear families with 713 individuals. There were
an additional 163 sibling pairs for BMI and an addi-
tional 117 sibling pairs for %fat. The mean BMI (34.1,
vs. 35.2) and %fat (39.1, vs. 41.3) for the 32 additional
families did not differ significantly from those in the 92
families initially used. The proportions of siblings ex-
ceeding the thresholds for BMI30 and%fat40 were
somewhat lower in the 32 additional families than in
the initial 92 families (36.5% vs. 59.8% for BMI and
20.2% vs. 36.8% for %fat). Although the proportion
of African Americans in the 32 additional families was
significantly higher than that in the initial sample
(32.3% vs. 10.5%; ; ), neither themean2x  54.5 P ! .01
BMI (35.7 kg/m2 vs. 35.9 kg/m2) nor the mean %fat
(40.5 vs. 40.8) differed significantly between Caucasians
and African Americans.
Simulations
The single-test empirical P values based on simula-
tions did not differ substantially from the nominal P
values provided by the linkage-analysis programs. How-
ever, multiple testing resulted in inflation of P values,
particularly for . When we controlled for mul-P  .05
tiple tests, nominal P values of .05 and .01 corresponded
to empirical P values of .189 and .022, respectively, and
empirical P values of .05 and .01 corresponded to nom-
inal P values of .0185 and .0055, respectively. Specific
single- and multiple-test empirical P values are given for
particular markers in tables 2 and 3 and are discussed
below.
Single-Point Analyses
First-stage genome scan.—Table 2 summarizes results
of the single-point analyses of the 354 framework mark-
ers from the initial genome scan. Nineteen analyses of
18 markers from 12 chromosomes had multiple-test em-
pirical P values .05, which is equivalent to 5.1% of
markers (18 of 354) and 0.9% of tests (19 of 2,144).
There was clustering of linkages on chromosomes 20
and 10. The positive chromosome 20 markers spanned
43 cM of the q arm and gave positive results for three
of four obesity phenotypes and for several analytic mod-
els. Two of the four markers, D20S200 and D20S107,
had multiple-test, empirical P values !.01, and the re-
maining two markers, D20S476 and D20S149, hadmul-
tiple-test, empirical P values close to .01. Positive results
for chromosome 10 markers were limited to the EMHE
analyses, primarily for BMI, and spanned a large interval
of 83 cM. Only one other marker (D2S439) from the
initial scan had a multiple-test empirical P value !.01
for the EMHE analysis of %fat.
Second-stage mapping of chromosome 20q.—From
the first-stage scan, evidence for linkage appeared most
strong and consistent for markers from chromosome
20q, across different analytical methods and different
phenotypes. We thus added 16 additional markers to
20q, for a total of 25 markers, and completed single-
point and multipoint analyses in an augmented sample
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Table 2
Summary of Single-Point Analyses of All Markers from Initial Genome Scan (354 Total)
with Multiple-Test Empirical P Values of .05 for the Six Phenotype # Analysis
Combinations
CHROMOSOME
AND MARKER
LOCATION
(cM) PHENOTYPE STATISTIC
P VALUE
Nominal
Empirical
Single
Test
Multiple
Test
1:
D1S194 206 %Fat EMHE .0126 .0105 .0297
2:
D2S439 257 %Fat EMHE .0031 .0015 .0045
3:
D3S1286 37 %Fat EMHE .0059 .0036 .0112
7:
D7S817 43 BMI EMHE .0116 .0090 .0265
8:
D8S560 46 %Fat EMHE .0106 .0085 .0239
9:
D9S1863 151 BMI EMHE .0185 .0171 .0499
10:
D10S1211 87 BMI EMHE .0081 .0060 .0166
D10S537 94 BMI EMHE .0074 .0053 .0148
D10S670 145 BMI EMHE .0109 .0085 .0248
D10S587 170 %Fat EMHE .0113 .0090 .0256
12:
D12S373 41 BMI EMHE .0102 .0077 .0226
13:
D13S168 50 %Fat EMHE .0108 .0087 .0245
16:
D16S539 118 %Fat EMHE .0095 .0072 .0207
17:
D17S796 16 BMI 30 NPL .0154 .0047 .0390
20:
D20S200 56 BMI EMHE .0036 .0020 .0056
D20S107 66 BMI EMHE .0024 .0011 .0032
D20S476 87 BMI 30 NPL .0066 .0017 .0126
D20S149 99 %Fat NPL .0057 .0003 .0106
D20S149 99 BMI 30 NPL .0120 .0033 .0279
of 124 nuclear families. Table 3 gives results for 14 anal-
yses of 11 20q markers having multiple-test empirical P
values !.05. Of those 11 markers, 3 (D20S107 [chro-
mosomal location 66 cM] D20S211 [chromosomal lo-
cation 91 cM], and D20S149 [chromosomal location 99
cM]) had multiple-test, empirical P values !.01. Because
of the large amount of computer time required for anal-
yses of the simulation data sets, empirical P values were
not computed for the remaining analyses; instead, nom-
inal P values are reported.
Our subsequent single-point parametric and nonpar-
ametric analyses using the MLINK and SIBPAIR pro-
grams strongly supported linkage for this region (fig. 1).
The results from ASP analysis (by SIBPAIR) for BMI
30 approached the thresholds for “significant” linkage
that have been proposed by Lander and Kruglyak
(1995).
For BMI30, the single-point MLINK analysis under
the affecteds-only model resulted in LOD scores of 3.06
( ) for D20S476, 3.02 ( ) forP  .00009 P  .0001
D20S211, and 1.85 ( ) for D20S149, whereasP  .00178
the ASP method gave LOD scores of 3.17 (P 
), 3.16 ( ), and 1.52 ( ),.000067 P  .000069 P  .004058
respectively (fig. 1). LOD scores were not significant for
either D20S902 ( for MLINK andP  .07595 P 
for ASP) or D20S102 ( for MLINK0.0819 P  .11118
and for ASP), which lie in the intervalsP  .100086
(D20S467–D20S211 and D20S211–D20S149, respec-
tively) separating the three linked markers. Information
content did not vary across the region, suggesting the
possibility of multiple linked loci.
For%fat40, the same three markers gave nominally
significant LOD scores, but these scores were not as high
as those for BMI30. The single-point LOD scores from
the MLINK analysis for D20S476, D20S211, and
D20S149 were 1.86 ( ), 1.59 (P  .001723 P 
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Figure 1 LOD scores for markers from chromosome 20, for
parametric single-point analyses implemented by MLINK (using an
affecteds-only model) and for nonparametric single-point ASP analyses
implemented by SIBPAIR. The upper panel shows the results for BMI
30, and the lower panel shows results for %fat 40.
Table 3
Summary of Single-Point Analyses of Markers from Saturation Mapping of Chromosome 20q
(25 Total) with Multiple-Test Empirical P Values of .05 for the Six Phenotype # Analysis
Combinations
MARKER
LOCATION
(cM) PHENOTYPE STATISTIC
P VALUE
Nominal
Empirical
Single Test Multiple Test
D20S471 47 %Fat EMHE .0113 .0090 .0256
D20S200 56 BMI EMHE .0098 .0073 .0215
D20S107 66 BMI EMHE .0012 .0005 .0014
D20S196 86 BMI 30 NPL .0154 .0047 .0389
%Fat 40 NPL .0062 .0015 .0118
D20S869 86.1 BMI 30 NPL .0142 .0041 .0349
D20S476 87 BMI 30 NPL .0182 .0058 .0486
D20S839 88.1 BMI 30 NPL .0143 .0041 .0351
D20S840 91 BMI 30 NPL .0163 .0050 .0421
D20S211 91.1 BMI 30 NPL .0025 .0005 .0034
D20S120 94 BMI 30 NPL .0104 .0029 .0233
D20S149 99 BMI 30 NPL .0087 .0022 .0185
%Fat 40 NPL .0044 .0011 .0075
%Fat NPL .0032 .0001 .0048
) and 2.04 ( ), respectively, whereas.003391 P  .001085
the single-point LOD scores from the SIBPAIR analysis
were 1.93 ( ), 1.18 ( ), and 1.89P  .00146 P  .01001
( ), respectively (fig. 1).P  .00161
Multipoint Analyses
The information content for markers used in the mul-
tipoint analyses exceeded 86% for the 20q region. Fig-
ures 2 and 3 summarize the results from our multipoint
analyses of the saturation of 20q. In general, these anal-
yses continued to support and strengthen findings from
the single-point analyses of BMI and %fat. However,
the results were not always consistent across different
phenotypes and different analytic methods.
For BMI, the support for linkage was strongest in the
BMI 30 analysis (fig. 2). The multipoint GENE-
HUNTER analysis provided strongest evidence of link-
age for D20S476 ( ; ) andNPL  2.55 P  .0035
D20S120 ( ; ), with a possibleNPL  2.59 P  .0031
third peak for D20S149 ( ; ).NPL  2.18 P  .0104
The results from the EMHE analysis of the quanti-
tative phenotype provided, in general, weaker support
for linkage than was provided by the BMI30 analysis.
For the EMHE analysis, the strongest evidence for link-
age was observed for D20S200 ( ), which isP  .0124
centromeric to markers supporting linkage in the other
analyses. For the NPL_QTL analysis, the pattern of the
peaks resembled the results from the BMI 30 analysis,
but the support for linkage was much weaker. For both
the EMHE and NPL_QTL statistics, D20S476,
D20S211, and D20S149 were not significant at nominal
P values of .05. In addition, the NPL_QTL analysis of
BMI, adjusted for sex and age (standardized residual),
yielded the same two primary peaks as were given by
the BMI 30 multipoint analysis. The two peaks, flank-
ing D20S196 and D20S120, showed the strongest sup-
port for linkage, and the NPL scores improved slightly
compared with the unadjusted NPL_QTL scores of
1.03–1.23 for D20S196 and 0.92–1.13 for D20S120.
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Figure 2 Results of three multipoint methods of analysis for the saturation markers from chromosome 20, with BMI used as the obesity
phenotype: the figure key (upper left) denotes, in order, NPL analysis implemented by GENEHUNTER, with BMI 30 as a discrete phenotype;
EMHE implemented by MAPMAKER/SIBS, with BMI as a quantitative phenotype; NPL statistics implemented by MAPMAKER/SIBS, with
BMI as a quantitative phenotype; NPL statistics when only females are used (FEM); and NPL statistics with standardized residuals, after
adjustment for sex and age (RSA). Distances between markers are given in centimorgans, and the y-axis refers to either the t or NPL score for
the analyses.
Subsequent, females-only analysis yielded a single peak
centering on D20S176, with an NPL score of 2.25
( ).P  .0062
For %fat, nearly all analyses revealed three peaks,
represented by D20S887, D20S120, and D20S149. (fig.
3). For D20S476 and D20S211, the two other markers
that were significant in the BMI 30 analysis, the NPL
scores were not as significant. D20S476 is ∼5.5 cM telo-
meric to D20S887, and D20S211 is ∼3.5 cM centro-
meric to D20S120; thus, the findings in this set of anal-
yses are similar to those from the BMI 30 analysis,
but the locations have been shifted slightly. As with BMI,
the results from the adjusted analysis (sex- and age-ad-
justed residual and females-only analyses) did not differ
from those from the unadjusted analyses. In addition,
the EMHEmethod revealed a single peak nearD20S471.
Race-Specific Analyses
We restricted our multipoint GENEHUNTER analy-
ses to Caucasians, to control for possible allele-frequency
differences between Caucasians and African Americans.
The results continued to support the findings from the
earlier, unstratified analyses. For BMI 30, three peaks
emerged, as before; however, the peaks were slightly
more centromeric compared with those from the un-
stratified analyses. D20S887 ( ; ),NPL  2.28 P  .0079
D20S839 ( ; ) and D20S913NPL  2.24 P  .0087
( ; ) showed the strongest evidenceNPL  2.44 P  .005
for linkage. However, the results for D20S476
( ; ), D20S120 ( ;NPL  2.2 P  .010 NPL  2.38 P 
), and D20S149 ( ; )—which.0058 NPL  2.10 P  .0131
are adjacent to the three markers mentioned
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Figure 3 Results of three multipoint methods of analysis, for the saturation markers from chromosome 20, when % body fat as measured
by BIA is used as the obesity phenotype: the figure key denotes, in order, NPL analysis implemented by GENEHUNTER, with %fat 40 as a
discrete phenotype; EMHE implemented by MAPMAKER/SIBS, with %fat as a quantitative phenotype; NPL statistics implemented by MAP-
MAKER/SIBS, with %fat as a quantitative phenotype; NPL statistics when only females are used (FEM); and NPL statistics with standardized
residuals, after adjustment for sex and age (RSA). Distances between markers are given in centimorgans (cM) and the y-axis refers to either
the t or NPL score for the analyses.
above—were also significant. These markers span ∼14
cM (72.0–85.6 cM). For %fat 40, the multipoint
GENEHUNTER analysis gave strongest evidence for
linkage for D20S178 ( ), D20S120 ( ),P  .008 P  .0056
and D20S149 ( ), and weaker findings wereP  .0063
observed for D20S476 ( ; ) andNPL  1.41 P  .03480
D20S211 ( ; ). There were tooNPL  1.04 P  .0896
few families ( ) for an African Americans–onlyn  10
analysis.
Discussion
We conducted a genome scan for closely related obe-
sity phenotypes in 92 nuclear families selected for ex-
treme obesity and thinness. Eighteen of 354 markers (19
of 2,124 tests [i.e., 5.1% of markers, 0.9% of tests]) had
multiple-test empirical P values.05 in the initial single-
point analyses, including quantitative and discrete anal-
yses of BMI and %fat. These positive results included
markers on chromosomes 1–3, 7–10, 12, 13, 16, 17,
and 20. Five of the 19 positive results were for four
markers from chromosome 20q. Given the uncertainties
associated with the identification of genes for multigenic
traits in humans, we placed relatively greater value on
consistency than on any particular P value from the in-
itial scan. Of the 12 chromosomes giving positive results
with multiple-test empirical P values !.05, only chro-
mosome 20 gave consistently positive results acrossmul-
tiple phenotypes, analytic methods, and markers. We
selected chromosome 20q for saturation mapping and
added an additional 16 20q markers, for an expanded
sample of 124 nuclear families.
Single- and multipoint results supported linkage to
20q13; however, the linked interval was large. The dis-
crete results for both BMI and %fat produced three
peaks focused on markers D20S476, D20S211, and
D20S149, with the results for BMI being somewhat
stronger than those for %fat, perhaps because of the
larger sample size for the BMI phenotype. The EMHE
quantitative analyses gave a more centromeric location
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Figure 4 Ideogram of human chromosome 20q. Markers are
listed to the right, with their respective chromosomal locations. Mark-
ers added for the saturation mapping are denoted by an asterisk (*).
The order of polymorphic markers was confirmed byMulti-Map anal-
ysis. Human obesity candidate genes are listed to the left. The map
order for the human candidate genes was based on databases cited in
the text; because of discrepancies among maps, gene order may be
different than the best estimate used here. Mouse obesity QTL loci
predicted to be homologous to this region are listed to the far left,
and denoted by number sign (#). In view of the uncertainty about gene
order and intermarker distance in cross-species mapping, these loca-
tions are approximate.
and weaker support for linkage than were given by the
other analytic methods.
Additional analyses, controlling for race, sex, and age,
gave results that were essentially the same as those from
the primary analyses. The insignificant effects of age and
gender on linkage analyses of our cohort may be due to
(a) the extreme nature and early onset of the obesity
observed in our sample and (b) the fact that most obese
family members were female.
When all the analyses were considered, therewas some
support for linkage over a 16-cM interval fromD20S176
to D20S149. However, the strongest support was for the
smaller, 10-cM interval in 20q13, containing markers
D20S476, D20S211, and D20S149. Markers in the in-
tervals between these markers did not support linkage,
suggesting the possibility of multiple linked genes af-
fecting obesity phenotypes in our sample.
Appropriate significance levels for linkage analyses of
complex traits are controversial. Diverse approaches
have been suggested, ranging from use of nominal P
values (Curtis 1996; Witte et al. 1996), Bonferroni cor-
rection (Wilson et al. 1991; Drigalenko and Elston
1997), simulation-based corrections (Weeks et al. 1990;
Norman et al. 1998), to specific critical values (Risch
1991; Lander and Kruglyak 1995; Morton 1998; Rao
1998). Results of our ownMonte Carlo simulations sug-
gested a genomewide significance level of approximately
for the 20q13 markers in the initial single-pointP ! .01
scan. Multipoint analyses provided additional support
and localization of linkage, and the affecteds-only anal-
yses gave nominal P values that approach even the most
stringent suggested criterion for “significance”—LOD
score 13.3 and (Lander and Kruglyak 1995).P ! .00005
On the basis of a single sample, it is difficult to unam-
biguously distinguish true from false linkage results.
However, linkage of obesity to the chromosome 20q13
region is supported by (1) the consistency of results
across related phenotypes and analytic methods, (2) the
extremely low P values from the sibling pair and para-
metric analyses, and (3) the results of our simulations.
Additional support for linkage to 20q comes from
linkages that other groups have reported for human obe-
sity, mouse obesity, and NIDDM (fig. 4). Borecki et al.
(1994) have reported suggestive linkage of BMI and a
sum of skin-fold measures to adenosine deaminase. Lem-
bertas et al. (1997) have reported linkage of %fat to
markers D20S197 and D20S120, which are close to our
markers D20S119 (distance ∼5 cM) and D20S476 (dis-
tance ∼7 cM), respectively. They also found linkage of
fat mass and BMI to the MC3R ( melanocortin receptor
3) gene, located near D20S149 (1 Mb [The Genetic
Location Database]). Norman et al. (1998) have re-
ported support for linkage of the 24-h respiratory quo-
tient to markers that are more centromeric (20q11) than
the markers found to be significant in our analyses. This
region of chromosome 20 also appears to contain two
or more genes for diabetes. One form of maturity-onset
diabetes of the young (i.e., MODY1) is caused by mu-
tations in the 4HNF4 (hepatic nuclear factor) gene, in
20q12 (Yamagata et al. 1996). Linkage to this region
has been reported for NIDDM also (Bowden et al. 1997;
Ji et al. 1997). Another NIDDM locus may lie just distal
to the interval linked to obesity in our study, near
the PCK1 (phosphoenolpyruvate carboxykinase 1) gene
(Zouali et al. 1997). Several mouse studies have sug-
gested that genes that influence body weight and fatness
in the mouse reside on chromosome 2, in regions ho-
mologous to human chromosome 20q (York et al. 1996;
Lembertas et al. 1997; Pomp 1997; Taylor and Phillips
1997; Mehrabian et al. 1998). The consistency of the
previous human linkage studies for obesity andNIDDM,
taken together with the evidence of cross-species ho-
mology of obesity genes, supports a role for chromosome
20q in human obesity.
The chromosome region 20q11-q13 contains several
genes that are plausible candidates for obesity (fig. 4).
Mutations of the agouti gene in mice lead to obesity
(Bultman et al. 1992; Miller et al. 1993), and the human
orthologue (i.e., agouti-signaling protein [ASIP]) is lo-
cated within the relevant region of human chromosome
20. ASIP is a potent inhibitor of alpha melanocyte-stim-
ulating–hormone receptors 3 and 4 (MC3R andMC4R)
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(Lu et al. 1994; Fong et al. 1997), and mice lacking a
functional MC4R gene are obese (Huszar et al. 1997).
It is currently unknownwhether knockouts of the related
MC3R gene would lead to an obese phenotype. Albright
hereditary osteodystrophy is a genetic disorder charac-
terized by skeletal and developmental defects and by
obesity (Gunay-Aygun et al. 1997). There are several
forms of this disorder, and at least two forms are as-
sociated with mutations of GNAS1 (guanine nucleo-
tide–binding protein), the gene that maps to human
chromosome 20q11-13. Within the linked interval,
CEBPB (CAAT/enhancer-binding–protein beta) is an-
other candidate gene, because of its role in adipocyte
differentiation (Yeh et al. 1995).
We previously had reported negative linkage for chro-
mosome 20, using a subset of the families that had been
collected earlier (Xu et al. 1995). Neither the current
nor the previous results supported linkage between
D20S476 and D20S149 when BMI and% body fat were
analyzed by the Haseman-Elston method. This disparity
of results from partially overlapping samples demon-
strates that negative reports may be useful only in ruling
out gene effects of specific types and sizes, depending on
the power associated with the particular sample size and
structure and, especially, method of analysis. In our sam-
ple, there is a greater range and variability among obese
individuals than between obese and normal-weight in-
dividuals (Price et al. 1998). Examination of obesity ex-
clusively as a quantitative phenotype, the approach of
the earlier report (Xu et al. 1995), may have masked
genotype-phenotype relationships, because the pheno-
type of obese subjects is labile compared with that of
normal-weight subjects; discrete thresholds for obesity
may be more stable (Reed and Price 1998a).
The three human genome–scan studies published to
date have implicated three distinct regions for obesity-
susceptibility loci (Comuzzie et al. 1997; Norman et al.
1998; present study). Since complex traits are hetero-
geneous by definition, the absence of complete agree-
ment among genome scans is not surprising. For ex-
ample, in mouse QTL breeding experiments, starting
with different strains of inbred mice yielded different but
overlapping sets of loci involved in body-weight regu-
lation (Pomp 1997; Chagnon et al. 1998). In humans,
as in the mouse, several genes with different effect sizes
could influence obese phenotypes. At least some of our
secondary findings should represent true linkages to
genes having relatively smaller effects in our sample. Be-
low, we describe positive support for linkage to other
chromosome markers, in the context of findings from
other studies.
We have observed positive support for linkage in other
chromosomes. D7S817 (43 cM) identifies one possible
candidate region, although it is located on the p arm,
far from known candidate genes or regions in 7q. We
previously had reported increased IBD sharing in ex-
tremely obese (BMI 40) sibling pairs, for chromosome
7q31 markers flanking the leptin gene (Reed et al. 1996).
The current analyses of less-extreme obesity (BMI 30)
provided little evidence for linkage to this region. How-
ever, we continue to find support for linkage between
more-extreme obesity phenotypes and the leptin gene
region (results not shown). Linkage and association find-
ings for the leptin gene have been mixed, with some
studies finding support for linkage (Borecki et al. 1994;
Clement et al. 1996; Comings et al. 1996; Duggirala et
al. 1996; Reed et al. 1996; Butler et al. 1997; Lapsys et
al. 1997; Roth et al. 1997), some finding marginal ev-
idence (Shintani et al. 1996; Oksanen et al. 1997a,
1997b), and others finding no evidence (Stirling et al.
1995; Bray et al. 1996; Norman et al. 1996, 1997, 1998;
Comuzzie et al. 1997; Hasstedt et al. 1997). A recent
metanalysis has reported a robust significance level when
multiple studies are combined (Allison and Heo 1998).
Polymorphisms in the 5′ UTR of the leptin gene that are
associated with obesity-related phenotypes have been de-
scribed (Hager et al. 1998; Mammes et al. 1998), pro-
viding further evidence that variability in the leptin gene
may influence common forms of obesity in humans.
Marker D1S194 (206 cM) lies in band q21-23, which
is homologous with both pig (Andersson et al. 1994)
and mouse QTL (Taylor and Phillips 1996). Addition-
ally, a gene for familial partial lipodystrophy, a genetic
disorder characterized by loss of subcutaneous adipose
tissue, maps to this region (Peters et al. 1998). The pos-
itive linkage on chromosome 2 (D2S439; 244.8 cM) is
distant from the linkage reported for plasma leptin levels
in Mexican Americans (Comuzzie et al. 1997). Marker
D3S1286 is near marker D3S2432, for which weak link-
age has been reported previously in Pima Indians (Nor-
man et al. 1997). D3S1286 appears to be 37 cM from
the homologous region for the mouse obesity locus
Dob2 (West et al. 1994) but is near the peroxisome
proliferative activated receptor (gamma) (PPARG). The
PPARG gene is expressed at high levels in adipoctyes
and at very low levels in other tissues and is involved
in adipocyte differentiation (e.g., see Shao and Lazar
1997). A polymorphism of this gene is associated with
plasma leptin levels in humans (Meirhaeghe et al. 1998).
Marker D8S560 is located near the LPL (lipoprotein
lipase) gene, in 8q22. Previous results of linkage and
association studies for the LPL gene have been mixed
(Comuzzie et al. 1995; Jemaa et al. 1995; Hasstedt et
al. 1997). The predominant effect of the mutations in
the LPL gene appears to be alterations in lipid metab-
olism (Mailly et al. 1997); however, one cannot rule out
the influence of the genes on body weight. Marker
D9S1863 is located in band 9q34. In a previous study
of sibling pairs ascertained through hypertensive pro-
bands, a marker located in 9q34 gave evidence for link-
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age to height, weight, and skin-fold thickness (Wilson
et al. 1991). The four positive chromosome 10 markers
span 83 cM, which includes most of 10q. Marker
D13S168 (50 cM) is near the ESD gene (esterase D),
previously linked to obesity phenotypes (Borecki et
al. 1994). The linked markers on chromosomes 12
(D12S373; 41 cM), 16 (D16S539; distal 16q), and 17
(D17S796; 16 cM, 17p12) are not near any known can-
didate genes or regions (Chagnon et al. 1998).
In summary, we have reported strong and significant
evidence for linkage between obesity phenotypes and
markers in 20q13. We have found consistency across
multiple obesity phenotypes, different analytic methods,
and several closely linked markers. Both simulation-
based and nominal P values support the significance of
our results. The linkage to markers in a region in 20q13
previously had been supported by both human linkage
studies and animal models. This chromosome region
should be targeted for further replication, fine mapping,
and gene-identification studies.
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